RAPT Therapeutics, Inc. Contracts & Agreements
43 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (5)
- Human Resources (10)
- Real Estate (4)
- Uncategorized (11)
- Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2024)
- Amendment No. 2, dated February 1, 2024, to the Clinical Trial Collaboration and Supply Agreement, dated as of November 1, 2018, by and between MSD International GmbH and RAPT... (Filed With SEC on March 7, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 11, 2023)
- Underwriting Agreement, dated November 17, 2022 (Filed With SEC on November 22, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 10, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on May 31, 2022)
- Securities Purchase Agreement, dated May 24, 2022, by and between RAPT Therapeutics, Inc. and the investor party thereto (Filed With SEC on May 31, 2022)
- Registration Rights Agreement, dated May 27, 2022, by and between RAPT Therapeutics, Inc. and the investor party thereto (Filed With SEC on May 31, 2022)
- Underwriting Agreement, dated June 15, 2021 (Filed With SEC on June 16, 2021)
- Description of Registrants Securities (Filed With SEC on March 30, 2020)
- Offer Letter, by and between Karen Lam and RAPT Therapeutics, Inc., dated July 10, 2019 (Filed With SEC on March 30, 2020)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 30, 2020)
- Form of Underwriting Agreement (Filed With SEC on February 4, 2020)
- Collaboration and License Agreement, dated as of December 1, 2019, by and between Hanmi Pharmaceutical Co., LTD. and RAPT Therapeutics, Inc (Filed With SEC on February 4, 2020)
- Offer Letter by and between RAPT Therapeutics, Inc. and Rodney Young, dated as of November 11, 2019 (Filed With SEC on December 4, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 22, 2019)
- Board of Directors Agreement, by and between Wendye Robbins and RAPT Therapeutics, Inc., dated October 11, 2019 (Filed With SEC on October 22, 2019)
- Form of Underwriting Agreement (Filed With SEC on July 22, 2019)
- Form of common stock certificate of RAPT Therapeutics, Inc (Filed With SEC on July 22, 2019)
- RAPT Therapeutics, Inc. 2019 Equity Incentive Plan (Filed With SEC on July 22, 2019)
- Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Stock Option Exercise under the 2019 Equity Incentive Plan (Filed With SEC on July 22, 2019)
- Form of Restricted Stock Unit Award Agreement and Restricted Stock Unit Grant Notice under the 2019 Equity Incentive Plan (Filed With SEC on July 22, 2019)
- RAPT Therapeutics, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on July 22, 2019)
- Form of Indemnification Agreement by and between RAPT Therapeutics, Inc. and each of its directors and executive officers (Filed With SEC on July 22, 2019)
- Amended and Restated Employee Offer Letter, by and between Brian Wong and RAPT Therapeutics, Inc., dated July 20, 2019 (Filed With SEC on July 22, 2019)
- Amended and Restated Employee Offer Letter, by and between William Ho and RAPT Therapeutics, Inc., dated July 20, 2019 (Filed With SEC on July 22, 2019)
- Amended and Restated Employee Offer Letter, by and between Dirk Brockstedt and RAPT Therapeutics, Inc., dated July 20, 2019 (Filed With SEC on July 22, 2019)
- Employee Offer Letter, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated March 17, 2016 (Filed With SEC on July 22, 2019)
- Separation and Consulting Agreement, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated March 19, 2019 (Filed With SEC on July 22, 2019)
- Amendment to the Separation and Consulting Agreement, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated April 30, 2019 (Filed With SEC on July 22, 2019)
- Board of Directors Agreement, by and between Linda Kozick and RAPT Therapeutics, Inc., dated November 15, 2016 (Filed With SEC on July 22, 2019)
- Board of Directors Agreement, by and between Michael F. Giordano and RAPT Therapeutics, Inc., dated January 12, 2018 (Filed With SEC on July 22, 2019)
- Board of Directors Agreement, by and between William Rieflin and RAPT Therapeutics, Inc., dated June 23, 2015 (Filed With SEC on July 22, 2019)
- Clinical Trial Collaboration and Supply Agreement, dated as of November 1, 2018, by and between MSD International GmbH and RAPT Therapeutics, Inc (Filed With SEC on July 22, 2019)
- Non-Employee Director Compensation Policy (Filed With SEC on July 22, 2019)
- Amended and Restated Investors Rights Agreement by and among RAPT Therapeutics, Inc. and certain of its stockholders, dated December 18, 2018 (Filed With SEC on July 5, 2019)
- RAPT Therapeutics, Inc. 2015 Stock Plan, as amended (Filed With SEC on July 5, 2019)
- Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Stock Option Exercise under the 2015 Stock Plan (Filed With SEC on July 5, 2019)
- First Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated April 29, 2015 (Filed With SEC on July 5, 2019)
- Second Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated April 16, 2018 (Filed With SEC on July 5, 2019)
- Third Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated December 13, 2018 (Filed With SEC on July 5, 2019)
- Clinical Trial Collaboration and Supply Agreement, dated as of November 1, 2018, by and between MSD International GmbH and RAPT Therapeutics, Inc (Filed With SEC on July 5, 2019)
- Lease, by and between HCP, Inc. and Flexus Biosciences, Inc., dated October 10, 2014 (Filed With SEC on July 5, 2019)
